Last $3.52 USD
Change Today +0.08 / 2.33%
Volume 1.3M
SQNM On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Harry F. Hixson Jr., Ph.D.

Chairman, Sequenom Inc.
AgeTotal Calculated CompensationThis person is connected to 32 board members in 3 different organizations across 7 different industries.

See Board Relationships
75--
As of Fiscal Year 2013

Background*

Dr. Harry F. Hixson, Jr., Ph.D. served as the Chief Executive Officer of Sequenom Inc. from September 28, 2009 to June 10, 2014. Dr. Hixson served as an Interim Chief Executive Officer of Sequenom Inc. Dr. Hixson Co-founded BrainCells Inc. and served as its Chief Executive Officer from July 2004 to September 2005. He served as the Chief Executive Officer of Elitra Pharmaceuticals Inc., from February 1998 to May 2003 and served as its President from June 1998 to May 2003. ...

Read Full Background

Corporate Headquarters*

3595 John Hopkins Court
San Diego, California 92121

United States

Phone: 858-202-9000
Fax: 858-202-9001

Board Members Memberships*

Former Chairman of the Board, Chief Executive Officer and President
Co-Founder
1993-Present
Director
2001-N/A
Former Chairman, Chairman of Nominating and Corporate Governance Committee and Member of Compensation Committee
2003-Present
Chairman
2004-Present
Independent Director, Chairman of Science Committee and Member of Corporate Governance & Nominating Committee
2006-2010
Former Director and Member of Audit Committee
2009-2010
Former Director, Member of Audit Committee and Member of Compensation Committee

Education*

Honorary Doctorate
Purdue University
PhD
Purdue University
ScD
Purdue University
BS
Purdue University
MBA
The University of Chicago

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SQNM:US $3.52 USD +0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEQUENOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.